FI963638A - Menetelmiä HIV-1-injektion diagnosoimiseksi ja hoitamiseksi - Google Patents

Menetelmiä HIV-1-injektion diagnosoimiseksi ja hoitamiseksi Download PDF

Info

Publication number
FI963638A
FI963638A FI963638A FI963638A FI963638A FI 963638 A FI963638 A FI 963638A FI 963638 A FI963638 A FI 963638A FI 963638 A FI963638 A FI 963638A FI 963638 A FI963638 A FI 963638A
Authority
FI
Finland
Prior art keywords
hiv
infection
diagnosis
procedures
treatment
Prior art date
Application number
FI963638A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI963638A0 (fi
Inventor
Angeline Douvas
Glenn Ehresmann
Yoshi Takehana
Original Assignee
Univ Southern California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Southern California filed Critical Univ Southern California
Publication of FI963638A0 publication Critical patent/FI963638A0/fi
Publication of FI963638A publication Critical patent/FI963638A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
FI963638A 1994-03-14 1996-09-13 Menetelmiä HIV-1-injektion diagnosoimiseksi ja hoitamiseksi FI963638A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21374394A 1994-03-14 1994-03-14
PCT/US1995/003236 WO1995025124A1 (en) 1994-03-14 1995-03-13 Methods to diagnose and treat hiv-1 infection

Publications (2)

Publication Number Publication Date
FI963638A0 FI963638A0 (fi) 1996-09-13
FI963638A true FI963638A (fi) 1996-11-13

Family

ID=22796323

Family Applications (1)

Application Number Title Priority Date Filing Date
FI963638A FI963638A (fi) 1994-03-14 1996-09-13 Menetelmiä HIV-1-injektion diagnosoimiseksi ja hoitamiseksi

Country Status (6)

Country Link
EP (1) EP0750636A1 (no)
JP (1) JPH10504798A (no)
CA (1) CA2185129A1 (no)
FI (1) FI963638A (no)
NO (1) NO963848L (no)
WO (1) WO1995025124A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2487300A (en) 1998-12-31 2000-07-31 Chiron Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
AU2002320314A1 (en) 2001-07-05 2003-01-21 Chiron, Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
US20030186849A1 (en) 2001-09-06 2003-10-02 Zimmer Robert H. Modified peptides and their use for the treatment of autoimmune diseases
WO2006110831A2 (en) * 2005-04-12 2006-10-19 Duke University Method of inducing neutralizing antibodies to human immunodeficiency virus
CN101588813A (zh) * 2005-04-12 2009-11-25 杜克大学 诱导人类免疫缺陷病毒的中和抗体的方法
JP2010523676A (ja) 2007-04-13 2010-07-15 デューク ユニバーシティ ヒト免疫不全ウイルスに対する中和抗体を誘導する方法
US9402917B2 (en) 2009-04-03 2016-08-02 Duke University Methods for the induction of broadly anti-HIV-1 neutralizing antibody responses employing liposome-MPER peptide compositions
US10076567B2 (en) 2013-09-27 2018-09-18 Duke University MPER-liposome conjugates and uses thereof
US10213482B2 (en) 2014-12-12 2019-02-26 Immupharma France Sa Methods of treating chronic inflammatory diseases

Also Published As

Publication number Publication date
NO963848D0 (no) 1996-09-13
AU2120595A (en) 1995-10-03
NO963848L (no) 1996-11-14
FI963638A0 (fi) 1996-09-13
WO1995025124A1 (en) 1995-09-21
JPH10504798A (ja) 1998-05-12
EP0750636A1 (en) 1997-01-02
AU694204B2 (en) 1998-07-16
CA2185129A1 (en) 1995-09-21

Similar Documents

Publication Publication Date Title
FI952926A0 (fi) Menetelmät allergioiden hoitamiseksi tai ehkäisemiMenetelmät allergioiden hoitamiseksi tai ehkäisemiseksi seksi
FI971969A (fi) Peräpukamien hoitoon tarkoitettuja koostumuksia ja käyttömenetelmä
NO952573D0 (no) Blandinger for behandling av diabetiske komplikasjoner
FI963281A (fi) Ureaasipohjainen rokote ja helicobakteeri-infektion hoito
DE69822410D1 (de) Modularkatheter zur Abbildung und Behandlung und Montageverfahren
FI970918A0 (fi) Yhdisteet ja menetelmät syövän hoitamiseksi
FI94028B (fi) Laite nenäsairauksien diagnoosia ja hoitoa varten
FI19992398A (fi) Menetelmä ja järjestely sydämen lyönnin tunnistamiseksi
FI951370A (fi) Tiatsolidinin ja oksatsolidinin johdannaiset, niiden valmistus ja lääkinnällinen käyttö
DE69635364D1 (de) Blutfilter und extrakorporaler Kreislauf
FI971568A (fi) Menetelmä resistenttien kasvainten hoitamiseksi
FI965204A (fi) Bromelaiinin lääkekäyttö
DE69603635T2 (de) Katheterstruktur für medizinische Behandlung
DE69620691D1 (de) Therapeutisches Mittel zur Behandlung der Hypercholesterinämie
BR9101494A (pt) Tratamento de tecidos
FI963638A (fi) Menetelmiä HIV-1-injektion diagnosoimiseksi ja hoitamiseksi
ATA113492A (de) Mehrfachbeutelsystem zur sterilen behandlung von menschlichen blutkonserven
FI971897A0 (fi) Ihmisen retrovirusinfektion detektointi
NO913117D0 (no) Fremgangsmaate for behandling av benoedeleggende sykdommer.
FI964113A0 (fi) Lääkekoostumus hoitamaan tardiivia dyskinesiaa ja sen käyttö
NO965591D0 (no) Kombinasjonsbehandling av HIV-infeksjon
FI963947A (fi) Täydellisesti liuennut luukudos ja menetelmä sen valmistamiseksi
FI963263A0 (fi) Bromelaiinin lääkinnällinen käyttö
DE69737088D1 (de) Therapeutisches agens zur behandlung von fiv infektionen
DE69522685D1 (de) Behandlung von blut-plasma

Legal Events

Date Code Title Description
MA Patent expired